In a mouse-cell lab model, self-assembling peptide bioinks supported 3D printing of neural scaffolds where stem cells stayed viable, attached, and differentiated within 7 days.
Up to 10 mmMaximum diameter of the self-standing peptide scaffolds successfully bioprinted in the study.
What the researchers found
Researchers successfully printed self-standing, ring-shaped peptide scaffolds up to 10 mm in diameter using a self-assembling peptide bioink and a microfluidic coaxial printhead.
Murine neural stem cells encapsulated by either printing strategy showed slightly lower initial viability than controls, but viability increased over time. By day 7, the cells had adhered, sprouted, and differentiated into neurons, astrocytes, and oligodendrocytes, supporting the idea that these peptide hydrogels can function as bioinks for nervous tissue engineering.
Why it matters
Nervous tissue engineering needs materials that can be printed into stable 3D shapes without damaging fragile cells. This paper suggests self-assembling peptide hydrogels may offer a biomimetic scaffold that supports both printing and early neural-cell maturation, which is important for building more realistic repair models.
The numbers in context
Up to 10 mm scaffold diameter · 2 cell-loading strategies · 7-day differentiation window
How the study worked
The team formulated a self-assembling peptide bioink from linear, branched, and functionalized peptides designed to support cell adhesion and differentiation. They optimized print settings and rheology using a microfluidic RX1 bioprinter with a coaxial printhead, then printed ring-shaped self-standing scaffolds. Mouse neural stem cells were incorporated using two different loading strategies, and the resulting constructs were evaluated for structure, cell viability, attachment, sprouting, and differentiation over time.
What this study cannot tell us
This was an early-stage tissue-engineering study, not a clinical trial. The work used murine neural stem cells rather than human cells, and the abstract does not provide detailed quantitative viability or differentiation results. It shows short-term promise over 7 days, but it does not establish long-term function, transplant performance, or therapeutic benefit in living nervous tissue.
How to read the evidence
This is preclinical biomaterials research using cultured murine neural stem cells, so it can show proof of concept but not clinical benefit in humans. The study is valuable for feasibility and mechanism, but it sits well below human therapeutic evidence.
When this study was published
Published in 2025, this is a recent paper and likely reflects current thinking in peptide-based neural tissue engineering, though the field is still evolving quickly.
The bigger picture
Peptide-based hydrogels are being explored as customizable biomaterials for regenerative medicine. This study adds to that field by showing that self-assembling peptides can serve not just as passive scaffolds but as printable bioinks that may help organize and support neural cells in three dimensions.
Questions still open
- How well would these peptide scaffolds support neural cells over longer time periods than 7 days?
- Would the same bioink perform as well with human neural stem cells or patient-derived cells?
- Can these printed scaffolds restore function after implantation in animal models of nerve or brain injury?
Common questions
Did this study test peptide scaffolds in people?
What was the main result of the paper?
Read the original research
3D bioprinting of biomimetic self-assembling peptides and neural stem cells for nervous tissue engineering.
Journal of materials chemistry. B, 13(44), 14386-14402
Citation
Mondésert, Hugues; Malloggi, Chiara; Lazzaro, Andrea; Sala, Giulia; Corvaglia, Valentina; Forouharshad, Mahdi; Gelain, Fabrizio. (2025). 3D bioprinting of biomimetic self-assembling peptides and neural stem cells for nervous tissue engineering.. Journal of materials chemistry. B, 13(44), 14386-14402. https://doi.org/10.1039/d5tb00279f